Mathematical modeling of the synergy between hyperthermia and radiotherapy in tumor treatment based on p53 signaling network

SUN Tingzhe

doi:10.11665/j.issn.1000-5048.20210314

Journal of China Pharmaceutical University > 2021 > 52(3): 361-370. > DOI: 10.11665/j.issn.1000-5048.20210314

SUN Tingzhe. Mathematical modeling of the synergy between hyperthermia and radiotherapy in tumor treatment based on p53 signaling network[J]. Journal of China Pharmaceutical University, 2021, 52(3): 361-370. DOI: 10.11665/j.issn.1000-5048.20210314

Citation:

PDF (2065 KB)

Mathematical modeling of the synergy between hyperthermia and radiotherapy in tumor treatment based on p53 signaling network

SUN Tingzhe

School of Life Sciences, Anqing Normal University, Anqing 246133, China

Funds: This study was supported by the National Natural Science Foundation of China (No.31971185) and the Key Projects for Outstanding Young Talents in Colleges and Universities of Anhui Province (No.gxyqZD2020031)

More Information

Received Date: January 06, 2021
Revised Date: May 30, 2021

Graphical Abstract

Abstract

Abstract

The aim of the current study was to investigate the synergistic effect between temperature and irradiation on p53 dynamics using mathematical model in p53 signaling pathway.Delayed differential equations were used to construct the dynamic p53 model. The accelerated τ-leap stochastic simulation algorithm was used to analyze the stochastic behavior.Loewe and Bliss combination indexes were used to calculate the synergy. Numerical simulations were performed in MATLAB software. Results showed that at relatively lower temperatures, the amplitude and characteristic pitch of p53 pulses varied with changing temperatures.The amplitude and duration of p53 pulses were highly variable. At temperatures below 39 °C, the amplitude of the first p53 pulse was increased when temperature was elevated, whereas the characteristic pitch of p53 pulses was decreased with increasing temperature.Under mild hyperthermia (≥ 41 °C), p53 pulses were disrupted and p53 proteins became steadily accumulated.The patterns of periodicity in auto-correlation plot gradually vanished when the temperature was increased. With the metrics of cumulative and maximal p53 levels, there existed notable synergistic effects between the temperature and irradiation doses. In addition, the effect of temperature on p53 dynamics was reversible.To sum up, temperature could significantly affect dynamic p53 patterns.Radiotherapy may also benefit from hyperthermia in tumor treatment.
- p53,
- mathematical model,
- hyperthermia,
- radiotherapy,
- DNA damage,
- tumor

FullText(HTML)

References (38)

References

[1]	. Proc Natl Acad Sci U S A，1957，43（9）：804-811.
[2]	Harper CV，Woodcock DJ，Lam C，et al. Temperature regulates NF-κB dynamics and function through timing of A20 transcription［J］. Proc Natl Acad Sci U S A，2018，115（22）：E5243-E5249.
[3]	Jentsch M，Snyder P，Sheng CB，et al. p53 dynamics in single cells are temperature-sensitive［J］. Sci Rep，2020，10（1）：1481.
[4]	Batchelor E，Loewer A. Recent progress and open challenges in modeling p53 dynamics in single cells［J］. Curr Opin Syst Biol，2017，3：54-59.
[5]	Bieging KT，Mello SS，Attardi LD. Unravelling mechanisms of p53-mediated tumour suppression［J］. Nat Rev Cancer，2014，14（5）：359-370.
[6]	Wu X，Bayle JH，Olson D，et al. The p53-mdm-2 autoregulatory feedback loop［J］. Genes Dev，1993，7（7a）：1126-1132.
[7]	Batchelor E，Mock CS，Bhan I，et al. Recurrent initiation：a mechanism for triggering p53 pulses in response to DNA damage［J］. Mol Cell，2008，30（3）：277-289.
[8]	Marcel V，van Long FN，Diaz JJ. 40 years of research put p53 in translation［J］. Cancers，2018，10（5）：152.
[9]	Tang QS，Su ZY，Gu W，et al. Mutant p53 on the path to metastasis［J］. Trends Cancer，2020，6（1）：62-73.
[10]	Gurpinar E，Vousden KH. Hitting cancers'' weak spots：vulnerabilities imposed by p53 mutation［J］. Trends Cell Biol，2015，25（8）：486-495.
[11]	Sund-Levander M，Forsberg C，Wahren LK. Normal oral，rectal，tympanic and axillary body temperature in adult men and women：a systematic literature review［J］. Scand J Caring Sci，2002，16（2）：122-128.
[12]	Byrne C，Lim CL. The ingestible telemetric body core temperature sensor：a review of validity and exercise applications［J］. Br J Sports Med，2007，41（3）：126-133.
[13]	Guilherme L，Kalil J. Rheumatic fever and rheumatic heart disease：cellular mechanisms leading autoimmune reactivity and disease［J］. J Clin Immunol，2010，30（1）：17-23.
[14]	ó’Fágáin C. Enzyme stabilization—recent experimental progress［J］. Enzym Microb Technol，2003，33（2/3）：137-149.
[15]	Pelaez F，Manuchehrabadi N，Roy P，et al. Biomaterial scaffolds for non-invasive focal hyperthermia as a potential tool to ablate metastatic cancer cells［J］. Biomaterials，2018，166：27-37.
[16]	Sun TZ，Cui J. A plausible model for bimodal p53 switch in DNA damage response［J］. FEBS Lett，2014，588（5）：815-821.
[17]	Tanaka T，Halicka HD，Traganos F，et al. Induction of ATM activation，histone H2AX phosphorylation and apoptosis by etoposide：relation to cell cycle phase［J］. Cell Cycle，2007，6（3）：371-376.
[18]	Hirai Y，Hayashi T，Kubo Y，et al. X-irradiation induces up-regulation of ATM gene expression in wild-type lymphoblastoid cell lines，but not in their heterozygous or homozygous Ataxia-telangiectasia counterparts［J］. Jpn J Cancer Res，2001，92（6）：710-717.
[19]	Hafner A，Bulyk ML，Jambhekar A，et al. The multiple mechanisms that regulate p53 activity and cell fate［J］. Nat Rev Mol Cell Biol，2019，20（4）：199-210.
[20]	Walerych D，Olszewski MB，Gutkowska M，et al. Hsp70 molecular chaperones are required to support p53 tumor suppressor activity under stress conditions［J］. Oncogene，2009，28（48）：4284-4294.
[21]	Arrhenius S. über die Reaktionsgeschwindigkeit bei der Inversion von Rohrzucker durch S?uren［J］. Z Physik Chem，1889，4：226-248.
[22]	Gajjar M，Candeias MM，Malbert-Colas L，et al. The p53 mRNA-Mdm2 interaction controls Mdm2 nuclear trafficking and is required for p53 activation following DNA damage［J］. Cancer Cell，2012，21（1）：25-35.
[23]	Chatterjee A，Vlachos DG，Katsoulakis MA. Binomial distribution based tau-leap accelerated stochastic simulation［J］. J Chem Phys，2005，122（2）：024112.
[24]	Foucquier J，Guedj M. Analysis of drug combinations：current methodological landscape［J］. Pharmacol Res Perspect，2015，3（3）：e00149.
[25]	Hsing A，Faller DV，Vaziri C. DNA-damaging aryl hydrocarbons induce Mdm2 expression via p53-independent post-transcriptional mechanisms［J］. J Biol Chem，2000，275（34）：26024-26031.
[26]	Ju J，Schmitz JC，Song B，et al. Regulation of p53 expression in response to 5-fluorouracil in human cancer RKO cells［J］. Clin Cancer Res，2007，13（14）：4245-4251.
[27]	Mayo LD，Dixon JE，Durden DL，et al. PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy［J］. J Biol Chem，2002，277（7）：5484-5489.
[28]	Rossi M，Demidov ON，Anderson CW，et al. Induction of PPM₁D following DNA-damaging treatments through a conserved p53 response element coincides with a shift in the use of transcription initiation sites［J］. Nucleic Acids Res，2008，36（22）：7168-7180.
[29]	Ma L，Wagner J，Rice JJ，et al. A plausible model for the digital response of p53 to DNA damage［J］. Proc Natl Acad Sci U S A，2005，102（40）：14266-14271.
[30]	Vilenchik MM，Knudson AG. Endogenous DNA double-strand breaks：production，fidelity of repair，and induction of cancer［J］. Proc Natl Acad Sci U S A，2003，100（22）：12871-12876.
[31]	M?nke G，Cristiano E，Finzel A，et al. Excitability in the p53 network mediates robust signaling with tunable activation thresholds in single cells［J］. Sci Rep，2017，7：46571.
[32]	Harton MD，Koh WS，Bunker AD，et al. p53 pulse modulation differentially regulates target gene promoters to regulate cell fate decisions［J］. Mol Syst Biol，2019，15（9）：e8685.
[33]	Chen X，Chen J，Gan ST，et al. DNA damage strength modulates a bimodal switch of p53 dynamics for cell-fate control［J］. BMC Biol，2013，11：73.
[34]	Yang RZ，Huang B，Zhu YT，et al. Cell type-dependent bimodal p53 activation engenders a dynamic mechanism of chemoresistance［J］. Sci Adv，2018，4（12）：eaat5077.
[35]	Purvis JE，Karhohs KW，Mock C，et al. p53 dynamics control cell fate［J］. Science，2012，336（6087）：1440-1444.
[36]	Soares PI，Ferreira IM，Igreja RA，et al. Application of hyperthermia for cancer treatment：recent patents review［J］. Recent Pat Anticancer Drug Discov，2012，7（1）：64-73.
[37]	Ohnstad HO，Castro R，Sun JC，et al. Correlation of TP53 and MDM2 genotypes with response to therapy in sarcoma［J］. Cancer，2013，119（5）：1013-1022.
[38]	Keizer EM，Bastian B，Smith RW，et al. Extending the linear-noise approximation to biochemical systems influenced by intrinsic noise and slow lognormally distributed extrinsic noise［J］. Phys Rev E，2019，99（5-1）：052417.

[1]	WANG Jiang, ZHAO Xueyan, FANG Weirong. Research progress in STAT3/Th17 cells and Sjögren syndrome[J]. Journal of China Pharmaceutical University, 2024, 55(3): 420-428. DOI: 10.11665/j.issn.1000-5048.2023041805
[2]	SHI Xiaoni, YANG Shaoqi, CHENG Yusi, CHAO Jie. PPP2R3A promotes silicosis by regulating the expression of p53[J]. Journal of China Pharmaceutical University, 2022, 53(4): 490-497. DOI: 10.11665/j.issn.1000-5048.20220412
[3]	LIU Li, ZHANG Qianwen, NONG Cheng, ZHANG Xi, XU Xiaoting, Mohammed Ismail, XIAO Li, JIANG Zhenzhou, ZHANG Luyong, SUN Lixin. Research progress of lncRNA regulating signal transduction pathway in liver diseases[J]. Journal of China Pharmaceutical University, 2020, 51(3): 277-286. DOI: 10.11665/j.issn.1000-5048.20200304
[4]	WAN Nanyan, JIANG Cuihua, GAO Meng, ZHANG Jian, YIN Zhiqi, PAN Ke. Paeoniflorin inhibits programmed cell death-1-ligand 1 expression in HepG2 cells by regulating JAK/STAT3 signal pathway[J]. Journal of China Pharmaceutical University, 2019, 50(2): 213-221. DOI: 10.11665/j.issn.1000-5048.20190213
[5]	QIAO Jianan, WANG Tingfang, ZHANG Can. Design, synthesis and bioactivities of 4-(3-sulfonylbenzene)amino-6-formylpyrrole［2, 3-d］ pyrimidine derivatives[J]. Journal of China Pharmaceutical University, 2017, 48(5): 554-562. DOI: 10.11665/j.issn.1000-5048.20170508
[6]	TAN Chengning, HUANG Jinghan, LI Chunhong, XIA Zhining, YANG Fengqing. Applications of proteomics in the study of cell signal pathways[J]. Journal of China Pharmaceutical University, 2017, 48(4): 384-395. DOI: 10.11665/j.issn.1000-5048.20170402
[7]	LIU Xiaofei, WANG Tingfang, JU Caoyun, ZHANG Can. Synthesis and JAK2 inhibitory activities of 4-phenyl-pyrrolo［2, 3-d］pyrimidine derivatives[J]. Journal of China Pharmaceutical University, 2017, 48(2): 150-156. DOI: 10.11665/j.issn.1000-5048.20170204
[8]	WANG Jing-song, SHEN Jing, ZHANG Ting, TANG Cong, REN Tian-nian, XI Tao. Ursolic acid downregulates COX-2 expression by suppressing the activation of ERK in A549 cells[J]. Journal of China Pharmaceutical University, 2011, 42(1): 68-72.
[9]	Changes of Expression and Functions of Dipeptide Transporter after Anoxia/reoxygenation in Caco-2 Cells[J]. Journal of China Pharmaceutical University, 2003, (1): 76-79.
[10]	Effects of 3 Tyrphostins on Recombinant Human Protein Kinase CK2 Holoenzyme[J]. Journal of China Pharmaceutical University, 2001, (6): 51-56.

Cited By

Cited by

Periodical cited type(6)

1.	朱秋梦，石佳琦，吕玮，张昕，肖云峰. 丁香酚对大鼠心肌缺血再灌注损伤的抑制作用及其机制. 山东医药. 2024(05): 7-11 .
2.	张艺馨，李双. 依托咪酯调控circ-CCND1/miR-214-5p分子轴减轻缺氧/复氧诱导的心肌细胞损伤. 中国药师. 2022(01): 6-11 .
3.	徐季轩，马晓静，陈泓颖，高小力，佟海英，屠鹏飞，安超，柴兴云. 我国主要少数民族医药防治缺血性心脏病研究概述. 中国实验方剂学杂志. 2022(17): 235-247 .
4.	赵汴霞，宛蕾. 人参皂苷Rd对人脐静脉内皮细胞凋亡保护的作用研究. 河南医学高等专科学校学报. 2022(04): 399-405 .
5.	劳慧敏，李燕宁，韩成恩，陈梦琦. 养心活血解毒方对CVB3诱导的病毒性心肌炎小鼠心肌损伤的保护作用. 时珍国医国药. 2021(03): 544-547 .
6.	张文超，方秧青，钟静红，张明. 粉防己碱通过JAK2-STAT3途径减轻心肌缺血/再灌注损伤. 解剖学杂志. 2021(04): 291-294+318 .

Other cited types(2)

Get Citation

PDF

XML

Article views (151) PDF downloads (723) Cited by(8)

Turn off MathJax

Article Contents

Abstract

References

Mathematical modeling of the synergy between hyperthermia and radiotherapy in tumor treatment based on p53 signaling network

Abstract

References

Related Articles

Cited by

Periodical cited type(6)

Other cited types(2)

Catalog

Mathematical modeling of the synergy between hyperthermia and radiotherapy in tumor treatment based on p53 signaling network

Abstract

References

Related Articles

Cited by

Periodical cited type(6)

Other cited types(2)

Catalog

Export File

Citation

Format

Content